Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways.

Saydam O, Senol O, Würdinger T, Mizrak A, Ozdener GB, Stemmer-Rachamimov AO, Yi M, Stephens RM, Krichevsky AM, Saydam N, Brenner GJ, Breakefield XO.

Cancer Res. 2011 Feb 1;71(3):852-61. doi: 10.1158/0008-5472.CAN-10-1219. Epub 2010 Dec 13.

3.

Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.

Lasota J, Wasag B, Dansonka-Mieszkowska A, Karcz D, Millward CL, Ryś J, Stachura J, Sobin LH, Miettinen M.

Lab Invest. 2003 Sep;83(9):1361-71.

PMID:
13679444
4.

Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.

Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP.

Neurosurgery. 1995 Oct;37(4):764-73.

PMID:
8559307
5.

The neurofibromatosis type 2 gene is inactivated in schwannomas.

Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA.

Hum Mol Genet. 1994 Jan;3(1):147-51.

PMID:
8162016
6.

Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.

Tahiri A, Leivonen SK, Lüders T, Steinfeld I, Ragle Aure M, Geisler J, Mäkelä R, Nord S, Riis ML, Yakhini Z, Kleivi Sahlberg K, Børresen-Dale AL, Perälä M, Bukholm IR, Kristensen VN.

Carcinogenesis. 2014 Jan;35(1):76-85. doi: 10.1093/carcin/bgt333. Epub 2013 Oct 8.

PMID:
24104550
7.

Molecular characterization of chromosome 22 deletions in schwannomas.

Bijlsma EK, Brouwer-Mladin R, Bosch DA, Westerveld A, Hulsebos TJ.

Genes Chromosomes Cancer. 1992 Oct;5(3):201-5.

PMID:
1384671
8.

cDNA microarray analysis of vestibular schwannomas.

Welling DB, Lasak JM, Akhmametyeva E, Ghaheri B, Chang LS.

Otol Neurotol. 2002 Sep;23(5):736-48.

PMID:
12218628
9.

A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.

Bruder CE, Ichimura K, Tingby O, Hirakawa K, Komatsuzaki A, Tamura A, Yuasa Y, Collins VP, Dumanski JP.

Hum Genet. 1999 May;104(5):418-24.

PMID:
10394935
10.

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.

Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J.

Hepatology. 2008 Jun;47(6):1955-63. doi: 10.1002/hep.22256.

11.

Analysis of mutations in the SCH gene in schwannomas.

Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJ.

Genes Chromosomes Cancer. 1994 Sep;11(1):7-14.

PMID:
7529050
12.

Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.

Kley N, Whaley J, Seizinger BR.

Glia. 1995 Nov;15(3):297-307. Review.

PMID:
8586465
13.

microRNAs as oncogenes and tumor suppressors.

Zhang B, Pan X, Cobb GP, Anderson TA.

Dev Biol. 2007 Feb 1;302(1):1-12. Epub 2006 Aug 16. Review.

14.

Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.

Zhu M, Yi M, Kim CH, Deng C, Li Y, Medina D, Stephens RM, Green JE.

Genome Biol. 2011 Aug 16;12(8):R77. doi: 10.1186/gb-2011-12-8-r77.

15.

New insight into the role of miRNAs in leukemia.

Zhang H, Chen Y.

Sci China C Life Sci. 2009 Mar;52(3):224-31. doi: 10.1007/s11427-009-0036-1. Epub 2009 Mar 18. Review.

PMID:
19294347
16.

Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2.

Kehrer-Sawatzki H, Udart M, Krone W, Baden R, Fahsold R, Thomas G, Schmucker B, Assum G.

Hum Genet. 1997 Jul;100(1):67-74.

PMID:
9225971
18.

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.

Fuse M, Kojima S, Enokida H, Chiyomaru T, Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M, Ichikawa T, Seki N.

J Hum Genet. 2012 Nov 26;57(11):691-9. doi: 10.1038/jhg.2012.95. Epub 2012 Aug 2.

PMID:
22854542
19.

The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.

Vo DT, Qiao M, Smith AD, Burns SC, Brenner AJ, Penalva LO.

RNA Biol. 2011 Sep-Oct;8(5):817-28. doi: 10.4161/rna.8.5.16041. Epub 2011 Sep 1.

PMID:
21881409
20.

The neurofibromatoses. Part 2: NF2 and schwannomatosis.

Lu-Emerson C, Plotkin SR.

Rev Neurol Dis. 2009 Summer;6(3):E81-6. Review.

PMID:
19898272

Supplemental Content

Support Center